Operon Biotechnologies Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Operon Biotechnologies General Information

Description

Supplier of synthetic DNA oligonucleotides. The company offers a wide range of oligos, probes and primers, as well as longmers and modified oligos.

Contact Information

Website
www.operon.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2211 Seminole Drive
  • Huntsville, AL 35805
  • United States
Primary Industry
Biotechnology
Acquirer
MWG Biotech
Vertical(s)
Corporate Office
  • 2211 Seminole Drive
  • Huntsville, AL 35805
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Operon Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Operon Biotechnologies‘s full profile, request access.

Request a free trial

Operon Biotechnologies Patents

Operon Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090203897-A1 Method of using polymer embedded solid supports for small scale oligonucleotide synthesis Inactive 08-Feb-2008
US-20070253870-A1 Specimen tube holder and shipping container Inactive 01-May-2006
US-7772439-B2 Compounds comprising a phosphoramidite moiety and a protecting group bonded to a linker chain, and reporter group bonded to the protecting group, used for the functionalization, derivatization and modification that can be introduced into nucleotides Inactive 25-Oct-2004
US-20060167240-A1 Compounds comprising a phosphoramidite moiety and a protecting group bonded to a linker chain, and reporter group bonded to the protecting group, used for the functionalization, derivatization and modification that can be introduced into nucleotides Active 25-Oct-2004
US-20040241872-A1 Liquid aspirating, dispensing, mixing, transferring and reacting device comprising ultraviolet and/or visible spectral analytical tools for monitoring and sceening nucleic acid products Inactive 17-Mar-2003 G01N35/1065
To view Operon Biotechnologies’s complete patent history, request access »

Operon Biotechnologies FAQs

  • When was Operon Biotechnologies founded?

    Operon Biotechnologies was founded in 1986.

  • Where is Operon Biotechnologies headquartered?

    Operon Biotechnologies is headquartered in Huntsville, AL.

  • What industry is Operon Biotechnologies in?

    Operon Biotechnologies’s primary industry is Biotechnology.

  • Is Operon Biotechnologies a private or public company?

    Operon Biotechnologies is a Private company.

  • What is Operon Biotechnologies’s current revenue?

    The current revenue for Operon Biotechnologies is .

  • When was Operon Biotechnologies acquired?

    Operon Biotechnologies was acquired on 08-Jan-2009.

  • Who acquired Operon Biotechnologies?

    Operon Biotechnologies was acquired by MWG Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »